Headlines

MID WEB AD_Vertical left side 426 pixels (height) x 170 pixels (width).gif

ESG safe, effective and durable for patients with in class III obesity

When combined with longitudinal nutritional support, endoscopic sleeve gastroplasty (ESG) is a safe and effective tool for adults with...

ESG safe, effective and durable for patients with in class III obesity

Comprehensive preoperative evaluations and individualised treatment plans reduced post-surgical ICU

Researchers from the King Hamad Univeristy Hospital, Muharraq, Bahrain, have reported much lower rate of intensive care unit (ICU)...

Bariatric surgery reverses remodelling and improvement in cardiac geometry and function

ESG safe, effective and durable for patients with in class III obesity

Low risk of bowel resection is low in patients presenting with small bowel obstruction post-RYGB

Research

Zepbound (tirzepatide) available in US pharmacies for adults living with obesity

Eli Lilly and Company has announced that Zepbound (tirzepatide) injection is now available in US pharmacies for adults with obesity (with...

Journal Watch 6/12/2023

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Comprehensive preoperative evaluations and individualised treatment plans reduced post-surgical ICU

Researchers from the King Hamad Univeristy Hospital, Muharraq, Bahrain, have reported much lower rate of intensive care unit (ICU)...

FDA approves Tonix’ Phase 2 Trial of TNX-2900 for Prader-Willi Syndrome

The FDA has cleared Tonix Pharmaceuticals’ Investigational New Drug (IND) application to support clinical development of TNX-2900...

Roche poised to enter anti-obesity medication market with agreement to acquire Carmot Therapeutics

Roche is poised to enter the lucrative anti-obesity medication market after entering into a definitive merger agreement to acquire Carmot...

Pemvidutide achieves 15.6% weight loss at 48 weeks

Topline results from the MOMENTUM Phase 2 obesity trial of pemvidutide has shown at week 48, subjects receiving pemvidutide achieved mean...

Night shift workers need support to manage weight and metabolic health

Work based policies must be designed to target barriers that night shift workers face when managing weight and metabolic health...

Clearmind Medicine’s obesity drug shows positive results in a pre-clinical trial

Clearmind Medicine, a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major...

Pfizer’s twice-daily danuglipron formulation to be discontinued after high rates of GI complaints

Topline data from Pfizer’s Phase 2b clinical trial investigating its oral Glucagon-like peptide-1 receptor agonist (GLP-1RA) candidate,...

Living with overweight impedes the body's immune response to SARS-CoV-2

Research led by University of Queensland has revealed that living with overweight can impair the body's antibody response to SARS-CoV-2...

US obesity organisations call for better testing and labelling of drugs for people with obesity

The Obesity Action Coalition (OAC) announces the publication of a ‘Joint statement in support of closing gaps in the drug approval...

Semaglutide associated with reductions in alcohol use disorder symptoms

Semaglutide specifically reduces the symptoms of alcohol use disorder (AUD), according to researchers at the University of Oklahoma...

Industry

Zepbound (tirzepatide) available in US pharmacies for adults living with obesity

Roche poised to enter anti-obesity medication market with agreement to acquire Carmot Therapeutics

Novo Nordisk to initiate study assessing CagriSema vs Tirzepatide

Fractyl expands ERASE Task Force to study underlying GLP-1-based pancreatic gene therapy for T2DM

All caught up?

See all news

New: Directory

Discover global suppliers of specialist bariatric services, treatments, products, and medical equipment.

Browse directory

Events

Headlines

Research

Industry

All caught up?

New: Directory

Discover global suppliers of specialist bariatric services, treatments, products, and medical equipment.

Events

(See all)

Fifth IBC Oxford World Congress

31st European Congress on Obesity

8th IFSO-APC MEETING and 10th CSMBS MEETING

XXVII World Congress IFSO MELBOURNE 2024

IFSO-EC 2024

4th London International Bariatric Surgery Symposium

Global Meeting of the MGB-OAGB

B.E.S.T. (Bariatric Endoscopic Surgical Trends)

7th Gulf Obesity Surgery Society International Conference

Tweets

Weekly Digest

Get a round-up of the main headlines from Bariatric News, directly to your inbox each week.

Get in touch!
Email: info@bariatricnews.net